Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
111-133
Author(s):
Andrea Amalfitano and Robin J. Parks
Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
Journal:
Current Gene Therapy
Volume:
2
Page:
161-171
Author(s):
Peter Loser, Andreas Huser, Moritz Hillgenberg, Daniel Kumin, Gerald W. Both and Christian Hofimann
Bone Marrow Stromal Cells as Targets for Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
195-209
Author(s):
An Van Damme, Thierry Vanden Driessche, Desire Collen and Marinee K.L. Chuah
Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes
Journal:
Current Gene Therapy
Volume:
2
Page:
227-234
Author(s):
Thomas Licht and Chrisitian Peschel
Oncolytic Viruses: Programmable Tumour Hunters
Journal:
Current Gene Therapy
Volume:
2
Page:
243-254
Author(s):
J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Journal:
Current Gene Therapy
Volume:
2
Page:
255-271
Author(s):
Karsten Brand
Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
387-401
Author(s):
M. Tolomeo and D. Simoni
Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
403-417
Author(s):
E.S. White, R.M. Strieter and D.A. Arenberg
Recent Progress in the Development of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
419-439
Author(s):
Sandor Eckhardt
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs